Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-28

Clinical Trial Update: Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults [Phase 4]

View source ↗

Summary

Phase 4 study evaluating pharmacokinetic interactions between artemether/lumefantrine and lopinavir/ritonavir-containing antiretroviral therapy in HIV-infected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coartem (artemether-lumefantrine)
  • Kaletra (lopinavir)

Snippet

Sponsor: University of Cape Town | Conditions: HIV Infections, Malaria | Phase 4 | Status: COMPLETED